Can donor-reported characteristics, like race and ethnicity, impact data quality for allogeneic cell therapies? That’s one of the questions our expert panelists will discuss during our upcoming webinar. You’ll walk away with a better understanding of: 

  • Efficiencies in donor selection to reduce uncertainties about HLA matching and improve patient outcomes 
  • HLA complexity in cell source selection 
  • How machine learning can inform your cell source selection 
  • How the proven transplant infrastructure can assist in the delivery of cell and gene therapies 
  • Equity within the cell and gene therapy space 

PANELISTS

Abeer Madbouly, PhD
Principal Bioinformatics Scientist
NMDP

Martin Maiers
Vice President, Research
NMDP

Stephen Sullivan, PhD, MBA, FRSM
Managing Director
Lindville Bio, Ltd.